We are live on ! Find out more
Mawer Investment Management

Mawer Investment Management Portfolio holdings

AUM $14.7B
1-Year Est. Return 12.5%
This Fund
S&P 500
This Quarter Est. Return
+8.9%
1 Year Est. Return
+12.5%
3 Year Est. Return
+48.6%
5 Year Est. Return
+72.73%
10 Year Est. Return
+305.03%
AUM
$19.5B
AUM Growth
+$812M
Cap. Flow
-$649M
Cap. Flow %
-3.32%
Top 10 Hldgs %
46.76%
Holding
114
New
10
Increased
35
Reduced
59
Closed
7

Top Buys

Rank Stock Value
1
SHEL icon
Shell
SHEL
+$58.1M
2
ABT icon
Abbott
ABT
+$49.9M
3
ABBV icon
AbbVie
ABBV
+$43.3M
4
EL icon
Estee Lauder
EL
+$38M
5
RHI icon
Robert Half
RHI
+$25.6M

Sector Composition

Rank Sector Weight
1 Financials 29.39%
2 Technology 21.03%
3 Industrials 15.14%
4 Healthcare 13.86%
5 Consumer Discretionary 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WAT icon
26
Waters Corp
WAT
$40.7B
$198M 1.01%
600,436
-4,216
-0.7% -$1.16M
SCCO icon
27
Southern Copper
SCCO
$164B
$194M 0.99%
2,456,053
-388,741
-14% -$26.7M
MRNA icon
28
Moderna
MRNA
$24.2B
$179M 0.91%
1,795,949
-25,399
-1% -$2.14M
INTU icon
29
Intuit
INTU
$92B
$173M 0.88%
276,434
-55,462
-17% -$30.6M
BDX icon
30
Becton Dickinson
BDX
$49.4B
$170M 0.87%
698,634
-14,200
-2% -$3.5M
ABT icon
31
Abbott
ABT
$190B
$169M 0.87%
1,536,240
+499,022
+48% +$49.9M
COR icon
32
Cencora
COR
$63.7B
$167M 0.85%
811,692
+85,876
+12% +$16.8M
RHI icon
33
Robert Half
RHI
$4.31B
$157M 0.8%
1,780,150
+322,183
+22% +$25.6M
DNB
34
DELISTED
Dun & Bradstreet
DNB
$156M 0.8%
13,296,962
-102,245
-0.8% -$1.04M
VZ icon
35
Verizon
VZ
$196B
$150M 0.77%
3,980,458
+270,718
+7% +$9.58M
MLM icon
36
Martin Marietta Materials
MLM
$33.3B
$141M 0.72%
282,619
+3,806
+1% +$1.72M
PAYX icon
37
Paychex
PAYX
$43.1B
$140M 0.72%
1,173,828
-43,935
-4% -$5.21M
SHW icon
38
Sherwin-Williams
SHW
$88.5B
$130M 0.67%
416,369
+8,548
+2% +$2.3M
MA icon
39
Mastercard
MA
$492B
$125M 0.64%
293,157
-3,998
-1% -$1.61M
WINA icon
40
Winmark
WINA
$1.33B
$115M 0.59%
276,571
-38,258
-12% -$16.1M
NKE icon
41
Nike
NKE
$61.3B
$107M 0.55%
982,644
+68,210
+7% +$7.33M
DHR icon
42
Danaher
DHR
$146B
$106M 0.54%
457,536
+1,128
+0.2% +$240K
JPM icon
43
JPMorgan Chase
JPM
$962B
$101M 0.51%
590,838
-67,528
-10% -$10.2M
AME icon
44
Ametek
AME
$58.8B
$88.9M 0.46%
538,887
-111,085
-17% -$16.9M
DFIN icon
45
Donnelley Financial Solutions
DFIN
$1.16B
$86.3M 0.44%
1,384,369
+383,828
+38% +$21.9M
CNXN icon
46
PC Connection
CNXN
$2.04B
$79.9M 0.41%
1,189,469
-218,913
-16% -$13M
CTSH icon
47
Cognizant
CTSH
$26.4B
$75.4M 0.39%
998,559
-118,811
-11% -$8.2M
GIC icon
48
Global Industrial
GIC
$1.5B
$75.3M 0.39%
1,939,649
-27,905
-1% -$994K
BWXT icon
49
BWX Technologies
BWXT
$15.5B
$73.9M 0.38%
962,721
-23,080
-2% -$1.77M
LIN icon
50
Linde
LIN
$226B
$73.1M 0.37%
178,008
-70,336
-28% -$27.7M

Similar funds

Mawer Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, Mawer Investment Management held 114 positions worth $19.5B, up 4.3% from $18.7B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Mawer Investment Management withdrew a net $649M in Q4 2023, closing 7 positions and reducing 59 holdings. Its most notable exit was Organon & Co, an estimated $223M position sold in full.

By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.

Against the trend, Mawer Investment Management opened a new position in AbbVie worth $46.1M.

  • Mawer Investment Management's largest Q4 2023 buy was AbbVie: 297,227 shares worth $46.1M.
  • Mawer Investment Management added most to Shell in Q4 2023, an estimated $58.1M increase.
  • Mawer Investment Management's biggest Q4 2023 reduction was Kenvue, cutting an estimated $138M.
  • Mawer Investment Management fully exited Organon & Co in Q4 2023, selling an estimated $223M.
  • Mawer Investment Management's ten largest holdings make up 47% of its $19.5B portfolio in Q4 2023.
  • Mawer Investment Management opened 10 new positions and closed 7 in Q4 2023.
  • Mawer Investment Management's portfolio value rose 4.3% quarter-over-quarter to $19.5B.

Based on Mawer Investment Management's 13F filing for Q4 2023, filed 7 Feb 2024.